• Integrated method of treatment the chronic pelvic pain in inflammtory processes of the women pelvic organs

Integrated method of treatment the chronic pelvic pain in inflammtory processes of the women pelvic organs

HEALTH OF WOMAN. 2016.10(116):104–106; doi 10.15574/HW.2016.116.104 

Integrated method of treatment the chronic pelvic pain in inflammtory processes of the women pelvic organs

Grek L. P.

SI «Dnipropetrovsk medical Academy of MH of Ukraine», Dnеpr

The article presents the role of pro- and anti-inflammatory cytokines in the process of chronic pelvic pain (CPP) in women with pelvic inflammatory disease; therapeutic treatment for the prevention of relapse and psychological disorders.

The objective: to determinate the role of the pro – and anti-inflammatory cytokines into the implementation of chronic pelvic pain syndrome (CPP) and to measure the performance of treatment which including pathophysiological factors of the woman’s pain with pelvic inflammatory disease

Patients and methods: The study involved 75 women with PID. The main group consisted of 40 women with CPPS, Group 2 – 35 patients with painless passage of (the comparison group). The assessment of pain using a visual analogue scale (VAS); Pain Questionnaire McGill; conducted psychological testing, determined by the content of cytokines (IL-10, IL-6, TNF-a) in the blood serum.

Results. Significantly elevated levels of TNF-a in the celebrated in the first group compared with the second (p<0.001), which is directly correlated with the duration of CPPS (r=0.422; p<0.001), the intensity of pelvic pain VAS (r=0.469; p<0.001), as well as moderate and severe symptoms of depression degree (r=0.333; p<0.05).

Conclusions. The therapeutic treatment what we offered contributed to the regression of the pain after 1 month as determined by VAS 45.3±1.4 mm and 3 months 31.3±1.4 mm; reduction of reactive anxiety and depressive disorders detected in 84.7% of patients; improving psycho-emotional and general condition, normalization of sleep observed in 88.3% of women.

Key words: inflammatory diseases of the pelvic organs, chronic pelvic pain, cytokines, personal anxiety.


1. Dubossarskaya ZM, Dubossarskaya YuA. 2008. Reproduktivnaya endokrinologiya (perinatalnyie, akusherskie i ginekologicheskie aspektyi): uchebno-metodicheskoe posobie. D, Lira LTD:415.

2. Barinov A. 2012. Nevropaticheskaya bol. Vrach 9:17–23.

3. Kagramanova ZhA. 2014. Razrabotka i obosnovanie kompleksnoy kliniko- immunologicheskoy diagnostiki i immunoterapii vospalitelnyih zabolevaniy matki i pridatkov. Avtoref. diss. d-ra med. nauk: spets.14.01.01 «Akusherstvo i ginekologiya». M:50.

4. Tatarchuk TF, Solskiy YaP. 2003. Endokrinnaya ginekologiya (klinicheskie ocherki): chast 1. K, ZapovIt:105–110.

5. Hronicheskaya tazovaya bol: rukovodstvo dlya vrachey. Pod red. AN Belovoy, VN Krupina. M, Antidor. 2007:572.

6. Mc Lachlan CS. 2007. Vascular inflammation. Text. Canadian Medical Association Journal. 13:134–136.

7. Cheong Y, William Stones R. 2006. Chronic pelvic pain: aetiology and therapy. Best Pract. Res. Clin. Obstet. Gynecol. 20(5):695–711. https://doi.org/10.1016/j.bpobgyn.2006.04.004; PMid:16765092

8. Dowlati Y, Herrmann N, Swardfager W, Liu H. 2010. A Meta-Analysis of Cytokines in Major Depression. Biol Psychiatry. 67:446–457. https://doi.org/10.1016/j.biopsych.2009.09.033; PMid:20015486

9. Sommer C, Kress M. 2004. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanism in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361:184–187. https://doi.org/10.1016/j.neulet.2003.12.007; PMid:15135924